Keywords: Pfizer, King Pharmaceuticals, Tender offer, Shareholder law suit

Pfizer extends $3.6 billion tender offer for King Pharma, as all conditions still not met

Article | 23 November 2010

Print This

Global drugs behemoth Pfizer (NYSE: PFE) has extended the expiration date of its tender offer for all outstanding shares of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in